ILEVRO

Product NDC: 0078-0743
Requested package NDC: 0078-0743-96
11-digit product format: 000780743
Labeler code: 0078
Product ID: 0078-0743_4e6e6db9-e1cf-83cb-e063-6294a90a2420
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: nepafenac
Dosage form: SUSPENSION/ DROPS
Route: OPHTHALMIC
Labeler: Novartis Pharmaceuticals Corporation
Application: NDA203491
Marketing category: NDA
Marketing start: 2012-12-20
Substance: NEPAFENAC
Active strength: 3 mg/mL
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0078-0743	0078-0743-96	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N203491-001	ILEVRO	NEPAFENAC	0.3%	SUSPENSION/DROPS / OPHTHALMIC		RLD, RS	2012-10-16

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N203491-001	9662398	2030-12-01		Drug product	2017-06-02
N203491-001	8921337	2032-03-31		Drug product	2015-06-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N203491-001	ILEVRO	0.3%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2012-10-16	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 3 · 117 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203491-001	7947295	2024-06-08	Drug product	2013-02-15	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203491-001	9662398	2030-12-01	Drug product	2017-06-02	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203491-001	8921337	2032-03-31	Drug product	2015-06-08	`5c6f7cd8ea54…`

Additional Listing Data#

Finished product: Yes
Brand name base: ILEVRO
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NEPAFENAC	3 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0J9L7J6V8C	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1362132	Internal RxNorm lookup
1365866	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f089b583-0310-4ca8-8d41-52b06b08d1ed	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e884a219-2715-9672-1489-3e3d6a8897e6	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0078-0743-03	2025-01-30	C162847	48780-1	2cef2736-81fe-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005
0078-0743-96	2025-01-30	C162847	48780-1	2cef2736-81fe-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 2005

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0078-0743-03	ILEVRO	3 mL in 1 BOTTLE	SUSPENSION/ DROPS	3	5
0078-0743-03	ILEVRO	1 in 1 CARTON	SUSPENSION/ DROPS	1	5
0078-0743-96	ILEVRO	1 in 1 CARTON	SUSPENSION/ DROPS	1	5
0078-0743-96	ILEVRO	0.8 mL in 1 BOTTLE	SUSPENSION/ DROPS	0.8	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0078-0743-03	ML - Milliliter	0078-0743	af0eb0ff-6cf8-4c1c-b651-88ec06006685	1	2021-04-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0078-0743	ILEVRO (NEPAFENAC) SUSPENSION/ DROPS [NOVARTIS PHARMACEUTICALS CORPORATION]	4	Current NDC, Legacy NDC, 4 package rows	20230421_f089b583-0310-4ca8-8d41-52b06b08d1ed.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ILEVRO	NEPAFENAC	Novartis Pharmaceuticals Corporation	f089b583-0310-4ca8-8d41-52b06b08d1ed	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 203491 application number: NDA203491 ndc (package): 0078-0743-96 ndc (product): 0078-0743 ndc11 (package): 00078074396
ILEVRO	NEPAFENAC	Harrow Eye, LLC	10f411d3-a81e-074a-e063-6294a90ab547	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 203491 application number: NDA203491

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0J9L7J6V8C	NEPAFENAC	78281-72-8	NEPAFENAC

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1365866	ILEVRO 0.3 % Ophthalmic Suspension	PSN	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1362132	nepafenac 0.3 % Ophthalmic Suspension	PSN	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1365866	nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]	SBD	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1362132	nepafenac 3 MG/ML Ophthalmic Suspension	SCD	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1365866	Ilevro 0.3 % Ophthalmic Suspension	SY	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1365866	Ilevro 3 MG/ML Ophthalmic Suspension	SY	f089b583-0310-4ca8-8d41-52b06b08d1ed	5
1362132	nepafenac 0.3 % Ophthalmic Suspension	SY	f089b583-0310-4ca8-8d41-52b06b08d1ed	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0078-0743-96	00078074396	1 BOTTLE in 1 CARTON (0078-0743-96) > .8 mL in 1 BOTTLE	1 bottle	2021-01-15	0000-00-00	Yes	No	Current